Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
28.35
+0.80 (2.90%)
Jun 30, 2026, 10:21 AM EDT - Market open
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $98.53 million as of June 30, 2026. Its market cap has increased by 1,006.58% in one year.
Market Cap
98.53M
Enterprise Value
116.71M
1-Year Change
1,006.58%
Ranking
Category
Stock Price
$28.35
Market Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $98.53M, an increase of 255.92%. That is a compound annual growth rate of 70.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 98.53M | 2.98% |
| Dec 31, 2025 | 95.69M | 2,376.40% |
| Dec 31, 2024 | 3.86M | -86.04% |
| Feb 16, 2024 | 27.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 99.77M |
| Lixte Biotechnology Holdings | 99.56M |
| Alps Group | 98.18M |
| Fortress Biotech | 98.00M |
| Cognition Therapeutics | 97.55M |
| Anixa Biosciences | 96.97M |
| Rein Therapeutics | 96.76M |
| ProMIS Neurosciences | 96.40M |